The Role of N6-Methyladenosine in Inflammatory Diseases

14Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

N6-Methyladenosine (m6A) is the most abundant epigenetic RNA modification in eukaryotes, regulating RNA metabolism (export, stability, translation, and decay) in cells through changes in the activity of writers, erasers, and readers and ultimately affecting human life or disease processes. Inflammation is a response to infection and injury in various diseases and has therefore attracted significant attention. Currently, extensive evidence indicates that m6A plays an essential role in inflammation. In this review, we focus on the mechanisms of m6A in inflammatory autoimmune diseases, metabolic disorder, cardio-cerebrovascular diseases, cancer, and pathogen-induced inflammation, as well as its possible role as targets for clinical diagnosis and treatment.

Cite

CITATION STYLE

APA

Xu, H., Lin, C., Yang, J., Chen, X., Chen, Y., Chen, J., … Hu, C. (2022). The Role of N6-Methyladenosine in Inflammatory Diseases. Oxidative Medicine and Cellular Longevity. Hindawi Limited. https://doi.org/10.1155/2022/9744771

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free